Tag: AMED

  • Home Health Care: BioScrip Inc (NASDAQ:BIOS), Amedisys Inc (NASDAQ:AMED), Addus Homecare Corporation (NASDAQ:ADUS), Almost Family Inc (NASDAQ:AFAM)

    Sidoti downgraded shares of BioScrip (NASDAQ:BIOS) from a buy rating to a neutral rating in a report issued on Thursday, TheFlyOnTheWall.com reports. BioScrip Inc (NASDAQ:BIOS) stock opened at $7.20 in last trading session, and closed at $7.28, trading in the range of $7.09 – $7.30. The stock showed a negative weekly performance of -1.62%.

    Amedisys Inc (NASDAQ:AMED) stock has an average recommendation of underweight with an average target price of $11.44. Amedisys Inc (NASDAQ:AMED) shares closed at $15.80 on last trade day, by decreasing -3.95%. Stock 52 week range is $8.81 – $18.70. Company’s market capitalization is $512.88 billion.

    Addus Homecare (NASDAQ:ADUS) stock was downgraded by Sidoti from a “buy” rating to a “neutral” rating in a research note issued on Tuesday, TheFlyOnTheWall.com reports. They currently have a $30.00 price objective on the stock. Sidoti’s price target points to a potential upside of 7.95% from the company’s current price. Addus Homecare Corporation (NASDAQ:ADUS) stock decreased -0.77% and finished the last session at $28.49. The EPS of the stock remained 1.06. Company’s market capitalization is $310.91 billion.

    Almost Family (NASDAQ:AFAM) was upgraded by investment analysts at EVA Dimensions from an “underweight” rating to a “hold” rating in a note issued to investors on Thursday, AR Network reports. Almost Family Inc (NASDAQ:AFAM) stock opened at $27.48 in last trading session and closed at $27.32. The 52 week range of the stock is $17.66 – $33.97 and the day range was $27.20 – $27.48.